Barkin Jodie A, Nemeth Zsuzsanna, Saluja Ashok K, Barkin Jamie S
From the *Division of Gastroenterology, Department of Medicine, †Department of Health Informatics, and ‡Department of Surgery, University of Miami, Leonard M. Miller School of Medicine, Miami, FL.
Pancreas. 2017 Sep;46(8):1035-1038. doi: 10.1097/MPA.0000000000000873.
Cannabis is the most frequently consumed illicit drug in the world, with higher prevalence under the age of 35 years. Cannabis was first reported as a possible cause of acute pancreatitis (AP) in 2004. The aim of this systematic review is to examine cannabis use as an etiology of AP.
A search using PubMed/Medline, Embase, Scopus, and Cochrane was performed without language or year limitations to May 1, 2016. Search terms were "Cannabis" and "Acute Pancreatitis" with all permutations. The search yielded 239 results. Acute pancreatitis was defined by meeting 2 of 3 Revised Atlanta Classification criteria. Cannabis-induced AP was defined by preceding use of cannabis and exclusion of common causes of AP when reported. Sixteen papers met inclusion criteria dating from 2004 to 2016.
There were 26 cases of cannabis-induced AP (23/26 men; 24/26 under the age of 35 y). Acute pancreatitis correlated with increased cannabis use in 18 patients. Recurrent AP related temporally to cannabis use was reported in 15 of 26. There are 13 reports of no further AP episodes after cannabis cessation.
Cannabis is a possible risk factor for AP and recurrent AP, occurring primarily in young patients under the age of 35 years. Toxicology screens should be considered in all patients with idiopathic AP.
大麻是全球最常被使用的非法药物,在35岁以下人群中的使用率更高。2004年,大麻首次被报道可能是急性胰腺炎(AP)的病因。本系统评价的目的是研究大麻使用作为AP病因的情况。
使用PubMed/Medline、Embase、Scopus和Cochrane进行检索,检索时间截至2016年5月1日,无语言或年份限制。检索词为“大麻”和“急性胰腺炎”的所有排列组合。检索结果共239条。急性胰腺炎根据修订的亚特兰大分类标准中的3条标准中的2条来定义。大麻诱导的AP通过先前使用大麻并在报告时排除AP的常见病因来定义。16篇论文符合2004年至2016年的纳入标准。
有26例大麻诱导的AP(23/26为男性;24/26年龄在35岁以下)。18例患者中,急性胰腺炎与大麻使用增加相关。26例中有15例报告复发性AP与大麻使用在时间上相关。有13篇报告称在停止使用大麻后未再出现AP发作。
大麻是AP和复发性AP的可能危险因素,主要发生在35岁以下的年轻患者中。所有特发性AP患者均应考虑进行毒理学筛查。